| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |